B6N.129P2(Cg)-Stat1tm1.1Bstr/Biat

Status

Available to order

EMMA IDEM:09916
International strain nameB6N.129P2(Cg)-Stat1tm1.1Bstr/Biat
Alternative nameB6.129P2-Stat1beta
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolStat1tm1.1Bstr
Gene/Transgene symbolStat1

Information from provider

ProviderMathias Müller
Provider affiliationDepartment for Biomedical Sciences, University of Veterinary Medicine Vienna (Vetmeduni Vienna)
Additional ownerProf. Thomas Rülicke, University of Veterinary Medicine, Institute of Laboratory Animal Science, Vienna, Austria
Genetic informationThe terminal portion of the cDNA for Stat1 fused in frame into exon 19 of the genomic Stat1alpha gene (accession no. AF349678). A human beta-globin splice and a floxed neomycin cassette were inserted downstream of the cDNAs and placed between two regions of homology. Offspring carrying the targeted alleles were crossed to Tg(CMV-cre) mice (Schwenk et al. 1995 Nucleic Acids Res. 23:5080–5081) to remove the neomycin cassette and subsequently intercrossed to obtain Stat1alpha/alpha homozygous mice.
Phenotypic informationHomozygous:
IFN gamma-dependent immunity against the bacterium Listeria monocytogenes; other immunological phenotypes

Heterozygous:
n/a
Breeding historyThe mice were backcrossed to the C57BL/6N background by speed congenics (Teppner et al. 2004; Lab Anim. 38:406–412. doi:10.1258/0023677041958882).
References
  • STAT1β is not dominant negative and is capable of contributing to gamma interferon-dependent innate immunity.;Semper Christian, Leitner Nicole R, Lassnig Caroline, Parrini Matthias, Mahlakõiv Tanel, Rammerstorfer Michael, Lorenz Karin, Rigler Doris, Müller Simone, Kolbe Thomas, Vogl Claus, Rülicke Thomas, Staeheli Peter, Decker Thomas, Müller Mathias, Strobl Birgit, ;2014;Molecular and cellular biology;34;2235-48; 24710278
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreUniversity of Veterinary Medicine, Vienna, Austria
Animals used for archivinghomozygous C57BL/6.Cg

Disease and phenotype information

IMPC phenotypes (gene matching)
  • increased monocyte cell number / IMPC
  • decreased mean corpuscular hemoglobin / IMPC
  • increased neutrophil cell number / IMPC
  • increased lymphocyte cell number / IMPC
  • abnormal gait / IMPC
  • impaired righting response / IMPC
  • decreased mean corpuscular volume / IMPC
  • enlarged lymph nodes / IMPC
  • decreased lymphocyte cell number / IMPC
  • decreased bone mineral content / IMPC
  • increased leukocyte cell number / IMPC
  • decreased circulating alkaline phosphatase level / IMPC
  • increased large unstained cell number / IMPC
  • increased eosinophil cell number / IMPC
  • increased basophil cell number / IMPC
MGI phenotypes (gene matching)
  • abnormal intestine morphology / MGI
  • abnormal tibia morphology / MGI
  • decreased body size / MGI
  • abnormal cornea morphology / MGI
  • multifocal hepatic necrosis / MGI
  • abnormal T cell activation / MGI
  • decreased level of surface class I molecules / MGI
  • increased mammary adenocarcinoma incidence / MGI
  • no abnormal phenotype detected / MGI
  • increased susceptibility to bacterial infection / MGI
  • increased susceptibility to viral infection / MGI
  • abnormal leukocyte physiology / MGI
  • abnormal macrophage physiology / MGI
  • increased IgG level / MGI
  • increased myocardial infarction size / MGI
  • abnormal cell cycle / MGI
  • abnormal redox activity / MGI
  • increased cardiomyocyte apoptosis / MGI
  • abnormal nitric oxide homeostasis / MGI
  • increased compact bone thickness / MGI
  • decreased B-1 B cell number / MGI
  • increased osteoclast cell number / MGI
  • increased bone resorption / MGI
  • decreased B cell number / MGI
  • abnormal response to infection / MGI
  • abnormal MHC II cell surface expression on macrophages / MGI
  • impaired natural killer cell mediated cytotoxicity / MGI
  • immune system phenotype / MGI
  • vision/eye phenotype / MGI
  • abnormal T-helper 2 physiology / MGI
  • increased bone mass / MGI
  • abnormal cell physiology / MGI
  • abnormal common myeloid progenitor cell morphology / MGI
  • increased NK T cell number / MGI
  • decreased NK cell number / MGI
  • increased CD4-positive, alpha beta T cell number / MGI
  • decreased CD8-positive, alpha-beta T cell number / MGI
  • decreased single-positive T cell number / MGI
  • decreased susceptibility to neuronal excitotoxicity / MGI
  • abnormal osteoblast differentiation / MGI
  • abnormal osteoclast differentiation / MGI
  • decreased interferon-gamma secretion / MGI
  • increased circulating interferon-gamma level / MGI
  • decreased circulating interferon-gamma level / MGI
  • increased circulating interleukin-12b level / MGI
  • decreased interleukin-1 beta secretion / MGI
  • decreased susceptibility to endotoxin shock / MGI
  • decreased NK cell degranulation / MGI
  • decreased hepatocyte apoptosis / MGI
  • decreased sensitivity to induced cell death / MGI
  • increased susceptibility to bacterial infection induced morbidity/mortality / MGI
  • tumor regression / MGI
  • abnormal NK cell physiology / MGI
  • increased effector memory CD8-positive, alpha-beta T cell number / MGI
  • increased trabecular bone volume / MGI
  • increased compact bone volume / MGI
  • increased macrophage nitric oxide production / MGI
  • lethality at weaning, complete penetrance / MGI
  • abnormal CD8-positive, naive alpha-beta T cell number / MGI

Literature references

  • STAT1β is not dominant negative and is capable of contributing to gamma interferon-dependent innate immunity.;Semper Christian, Leitner Nicole R, Lassnig Caroline, Parrini Matthias, Mahlakõiv Tanel, Rammerstorfer Michael, Lorenz Karin, Rigler Doris, Müller Simone, Kolbe Thomas, Vogl Claus, Rülicke Thomas, Staeheli Peter, Decker Thomas, Müller Mathias, Strobl Birgit, ;2014;Molecular and cellular biology;34;2235-48; 24710278

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).